Non-Severe Hypoglycemia Episodes (Nshes) Clinical And Economic Outcomes- A Comparison Between Sulfonylurea (Su) And Sodium-Glucose Co-Transporter 2 Inhibitor (Sglt2i) As Add On To Metformin From A Canadian Perspective
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.277
https://www.valueinhealthjournal.com/article/S1098-3015(18)32634-2/fulltext
Title :
Non-Severe Hypoglycemia Episodes (Nshes) Clinical And Economic Outcomes- A Comparison Between Sulfonylurea (Su) And Sodium-Glucose Co-Transporter 2 Inhibitor (Sglt2i) As Add On To Metformin From A Canadian Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32634-2&doi=10.1016/j.jval.2018.07.277
First page :
Section Title :
Open access? :
No
Section Order :
249